More and more teens are trying - and failing - to quit vaping

Embargoed until: Publicly released: 2025-11-04 03:00

International

Photo by Sebastian Radu on Unsplash

Youth vaping might have dropped slightly, but the habits are solidifying, according to international researchers who say more and more teens are struggling to quit the habit. The team looked at data from 115,191 young people in the 8^th to 12^th grades in the US, and found the prevalence of having vaped in the past 30 days had declined from 2020 to 2024. However, among those who did vape, the prevalence of daily vaping rose from 15% to 29%, and unsuccessful quit attempts increased from 28% to 53%. This trend raises concerns, the team adds, as daily vaping is associated with worse heart, respiratory, addiction, and mental health outcomes.

Media release

From: JAMA

Trends in Daily Nicotine Vaping and Unsuccessful Quit Attempts in Youths

JAMA Network Open
Original Investigation

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

About The Study: The findings of this study suggest that the U.S. youth nicotine vaping population recently became increasingly represented by daily use and unsuccessful quit attempts, a trend of which clinicians and policy makers should be aware.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo lifts. Embed this link to provide your readers free access to the full-text article.

Journal/
conference: JAMA Network Open

Research:Paper

Organisation/s: Children’s Hospital of Los Angeles, USA

Funder: Research reported in this publication was supported by awards K23DA055736 (Dr Masonbrink), K99DA058241 (Dr Han), and K24048160 (Dr Leventhal) from the NIDA, National Institutes of Health and award U54180905 from the National Cancer Institute and US Food and Drug Administration (Dr Leventhal). Conflict of Interest Disclosures: Dr Miech reported receiving grants from the National Institute on Drug Abuse (NIDA) during the conduct of the study. Dr Harlow reported receiving grants from the NIDA during the conduct of the study. No other disclosures were reported.

Media Contact/s

Contact details are only visible to registered journalists.